Comparative effectiveness of revascularization strategies.
N. Engl. J. Med., Apr;366(16):1467-76 (2012)
Long-term follow-up of polytetrafluoroethylene-covered stents implanted during percutaneous coronary intervention for management of acute coronary perforation.
Catheter Cardiovasc Interv., Jul;80(1):53-7 (2012)
Prediction of long-term mortality after percutaneous coronary intervention in older adults: results from the National Cardiovascular Data Registry.
Circulation., Mar;125(12):1501-10 (2012)
The cost-effectiveness of percutaneous coronary intervention as a function of angina severity in patients with stable angina.
Circ Cardiovasc Qual Outcomes., Mar;4(2):172-82 (2011)
Prepregnancy body mass index as an independent risk factor for pregnancy-induced hypertension.
J Womens Health (Larchmt)., Jan;20(1):67-72 (2011)
Coronary artery disease: revascularization strategies for patients with CAD and diabetes.
Nat Rev Cardiol., Jul;7(7):364-6 (2010)
Survival and neurologic recovery in patients with ST-segment elevation myocardial infarction resuscitated from cardiac arrest.
J. Am. Coll. Cardiol., Feb;53(5):409-15 (2009)
Determining the in-hospital cost of bleeding in patients undergoing percutaneous coronary intervention.
J Interv Cardiol., Jun;22(3):266-73 (2009)
The risk of cardiovascular events in primary care patients following an episode of severe hypertension.
J Clin Hypertens (Greenwich)., Apr;11(4):175-82 (2009)
Cost effectiveness of enoxaparin in acute ST-segment elevation myocardial infarction: the ExTRACT-TIMI 25 (Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction 25) study.
J. Am. Coll. Cardiol., Sep;54(14):1271-9 (2009)
The limits of cost-effectiveness analysis.
Circ Cardiovasc Qual Outcomes., Jan;2(1):55-8 (2009)
Pharmacoeconomic concepts in antiplatelet therapy: understanding cost-effectiveness analyses using clopidogrel as an example.
J. Cardiovasc. Pharmacol. Ther., Jun;13(2):107-19 (2008)
Effect of PCI on quality of life in patients with stable coronary disease.
N. Engl. J. Med., Aug;359(7):677-87 (2008)
Cost-effectiveness of percutaneous coronary intervention in optimally treated stable coronary patients.
Circ Cardiovasc Qual Outcomes., Sep;1(1):12-20 (2008)
Is an invasive interventional strategy of value in non-ST-elevation acute coronary syndromes?
Nat Clin Pract Cardiovasc Med., Dec;5(12):754-5 (2008)
The pathophysiology and burden of restenosis.
Am. J. Cardiol., Sep;100(5A):3K-9K (2007)
Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: A pooled analysis of over 21,000 subjects from 27 clinical trials.
Atherosclerosis., Aug;223(2):251-61 (2012)
A large pheochromocytoma with invasion of multiple local organs.
J Clin Hypertens (Greenwich)., Jan;13(1):60-4 (2011)
Emergency department tachypnea predicts transfer to a higher level of care in the first 24 hours after ED admission.
Acad Emerg Med., Jul;17(7):718-22 (2010)
Safety profile of statins alone or combined with ezetimibe: a pooled analysis of 27 studies including over 22,000 patients treated for 6-24â??weeks.
Cutting through the statistical fog: understanding and evaluating non-inferiority trials.
Int. J. Clin. Pract., Sep;64(10):1359-66 (2010)